Literature DB >> 11798456

Lung cancer in pregnancy: case reports and review of the literature.

K Mujaibel1, A Benjamin, M F Delisle, K Williams.   

Abstract

Lung cancer diagnosed in pregnancy is rare. The number of reported cases has been escalating in recent years, probably reflecting the increasing number of women of reproductive age who smoke. This review presents three cases of lung cancer in pregnancy with different manifestations and outcomes, with a review of the literature. Physicians should have a low threshold using different diagnostic tools for investigating unusual symptoms during pregnancy without fear for fetal safety. Once diagnosed, lung cancer represents a major ethical and medical dilemma. The optimal management of lung cancer in pregnancy is not known, because of the rarity of the cases reported during pregnancy and insufficient follow-up data.

Entities:  

Mesh:

Year:  2001        PMID: 11798456     DOI: 10.1080/714052775

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN: 1057-0802


  3 in total

1.  Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer.

Authors:  Lei Yang; Yun-Ting He; Jin Kang; Ming-Ying Zheng; Zhi-Hong Chen; Hong-Hong Yan; Xu-Chao Zhang; Jin-Ji Yang; Yi-Long Wu; Qing Zhou
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

2.  Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy.

Authors:  Gina Amanda; Agus Dwi Susanto; Dicky Soehardiman; Dianiati Kusumo Sutoyo; Yuyun Lisnawati; Boy Busmar; Andika Chandra Putra; Erlang Samoedro; Elisna Syahruddin
Journal:  Lung India       Date:  2017 Nov-Dec

3.  Rapid Progression of Lung Cancer Following Emergency Caesarean Section Led to Postpartum Acute Respiratory Failure.

Authors:  Tamami Watanabe; Takeshi Yamashita; Hitoshi Sugawara; Takahiko Fukuchi; Akira Ishii; Yoshiaki Nagai; Fumiyoshi Ohyanagi; Shinichiro Koyama; Junko Ushijima; Kenjiro Takagi; Akira Tanaka
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.